Table 2 Proposed ethical guidelines for clinical innovation in psychopharmacology
From: The ethics of clinical innovation in psychopharmacology: Challenging traditional bioethics
1 | Use of a treatment based on a viable hypothesis, with a plausible biological, empirical, or theoretical basis |
2 | Intention to report one's experience for the scrutiny and benefit of the scientific community |
3 | Willingness to report unexpected observations, perhaps initially noted without an a priori hypothesis. |
4 | Acceptance of a uniquely high standard of informed consent, not simply for medico-legal purposes, but on ethical grounds |